Cargando…
Recently Approved and Upcoming Treatments for Narcolepsy
Narcolepsy is a chronic, disabling neurologic disorder characterised by excessive daytime sleepiness (EDS) and, in up to 60% of patients, cataplexy. Treatments for narcolepsy are aimed at improving wakefulness (e.g. modafinil, armodafinil, stimulants), reducing cataplexy attacks (e.g. sodium oxybate...
Autor principal: | Thorpy, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982634/ https://www.ncbi.nlm.nih.gov/pubmed/31953791 http://dx.doi.org/10.1007/s40263-019-00689-1 |
Ejemplares similares
-
Recent advances in treatment for narcolepsy
por: Barateau, Lucie, et al.
Publicado: (2019) -
Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know
por: Krahn, Lois E., et al.
Publicado: (2021) -
Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment
por: Morse, Anne Marie, et al.
Publicado: (2023) -
Overview of approved and upcoming vaccines for SARS-CoV-2: a living review
por: Alderson, Jennifer, et al.
Publicado: (2021) -
Upcoming treatments for morphea
por: Wenzel, Dan, et al.
Publicado: (2021)